Medication safety group revises its list of high-risk medications
Patient Safety Monitor Alert, February 18, 2004
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
The Institute for Safe Medication Practices (ISMP) has updated its list of high-alert medications. Its new list identifies 33 different drugs or drug classifications that practitioners have frequently considered to be high-alert medications (http://www.ismp.org).
A high-alert medication is a drug that has a high risk of causing injury to patients when misused. Errors with the drugs are not necessarily more common than with other drugs, but their consequences can be more devastating.
The ISMP expects organizations to use the list to identify medications that require special safeguards to reduce the risk of errors. Safeguards may include limiting access to certain drugs, using auxiliary labels and automated alerts, and standardizing how the drugs are ordered, prepared, and administered.
The updated list includes the following:
Class/category of medications
- adrenergic agonists, IV (e.g., epinephrine)
- adrenergic antagonists, IV (e.g., propranolol)
- anesthetic agents, general, inhaled and IV (e.g., propofol)
- cardioplegic solutions
- chemotherapeutic agents, parenteral and oral
- dextrose, hypertonic, 20% or greater
- dialysis solutions, peritoneal and hemodialysis
- epidural or intrathecal medications
- glycoprotein IIb/IIIa inhibitors (e.g., eptifibatide)
- hypoglycemics, oral
- inotropic medications, IV (e.g., digoxin, milrinone)
- liposomal forms of drugs (e.g., liposomal amphotericin B)
- moderate sedation agents, IV (e.g., midazolam)
- moderate sedation agents, oral, for children (e.g., chloral hydrate)
- narcotics/opiates, IV and oral (including liquid concentrates, immediate- and sustained- release)
- neuromuscular blocking agents (e.g., succinylcholine)
- radiocontrast agents, IV
- thrombolytics/fibrinolytics, IV (e.g., tenecteplase)
- total parenteral nutrition solutions
- IV amiodarone
- colchicine injection
- heparin, low molecular weight, injection
- heparin, unfractionated, IV
- insulin, subcutaneous and IV
- IV lidocaine
- magnesium sulfate injection
- methotrexate, oral, non-oncologic use
- nesiritide
- nitroprusside, sodium, for injection
- potassium chloride for injection concentrate
- potassium phosphates injection
- sodium chloride injection, hypertonic, more than 0.9% concentration
- warfarin
Want to receive articles like this one in your inbox? Subscribe to Patient Safety Monitor Alert!
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- Running an effective peer review committee meeting
- HealthDataInsights posts new issues for medical necessity claims
- Sneak Peek: Effort underway to establish caseload benchmarks
- Q/A: Coding for telescopic intraocular lens
- New FAQ posted on storing laryngoscope blades
- Tip: Perform your own internal investigation prior to government audit
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- E-mailed
-
- Running an effective peer review committee meeting
- HIPAA Q&A: Flu shot requirement for hospital employees
- HHS task force: Consider privacy, security with text messages
- What does case-mix index mean to you?
- Q/A: Coding for telescopic intraocular lens
- Q/A: Correct use of modifier -PT
- Tip: Correctly code bilateral pain management procedures
- "Wall fountains" may be spreading Legionnaires to patients, visitors
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Case Management Monthly, March 2012
- Searched
